↓ Skip to main content

Psychedelic-Assisted Psychotherapy: A Paradigm Shift in Psychiatric Research and Development

Overview of attention for article published in Frontiers in Pharmacology, July 2018
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#50 of 20,055)
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

news
24 news outlets
blogs
2 blogs
policy
1 policy source
twitter
105 X users
patent
1 patent
facebook
4 Facebook pages
wikipedia
5 Wikipedia pages
reddit
2 Redditors
video
1 YouTube creator

Citations

dimensions_citation
134 Dimensions

Readers on

mendeley
512 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Psychedelic-Assisted Psychotherapy: A Paradigm Shift in Psychiatric Research and Development
Published in
Frontiers in Pharmacology, July 2018
DOI 10.3389/fphar.2018.00733
Pubmed ID
Authors

Eduardo Ekman Schenberg

Abstract

Mental disorders are rising while development of novel psychiatric medications is declining. This stall in innovation has also been linked with intense debates on the current diagnostics and explanations for mental disorders, together constituting a paradigmatic crisis. A radical innovation is psychedelic-assisted psychotherapy (PAP): professionally supervised use of ketamine, MDMA, psilocybin, LSD and ibogaine as part of elaborated psychotherapy programs. Clinical results so far have shown safety and efficacy, even for "treatment resistant" conditions, and thus deserve increasing attention from medical, psychological and psychiatric professionals. But more than novel treatments, the PAP model also has important consequences for the diagnostics and explanation axis of the psychiatric crisis, challenging the discrete nosological entities and advancing novel explanations for mental disorders and their treatment, in a model considerate of social and cultural factors, including adversities, trauma, and the therapeutic potential of some non-ordinary states of consciousness.

X Demographics

X Demographics

The data shown below were collected from the profiles of 105 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 512 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 512 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 89 17%
Student > Master 70 14%
Researcher 39 8%
Student > Ph. D. Student 30 6%
Student > Doctoral Student 28 5%
Other 67 13%
Unknown 189 37%
Readers by discipline Count As %
Psychology 100 20%
Medicine and Dentistry 72 14%
Neuroscience 45 9%
Social Sciences 17 3%
Pharmacology, Toxicology and Pharmaceutical Science 13 3%
Other 60 12%
Unknown 205 40%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 279. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 October 2023.
All research outputs
#131,484
of 25,936,091 outputs
Outputs from Frontiers in Pharmacology
#50
of 20,055 outputs
Outputs of similar age
#2,724
of 342,604 outputs
Outputs of similar age from Frontiers in Pharmacology
#2
of 395 outputs
Altmetric has tracked 25,936,091 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 20,055 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.4. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 342,604 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 395 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.